The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952
Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
Ware, J. E., & Gandek, B. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00081-x · Cited by 2,605
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S., Caplan, L., Linthorst, G. E., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450102 · Cited by 1,559
Self-citationEnzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial
Schiffmann, R., Kopp, J. B., Austin III, H. A., Sabnis, S., Moore, D. F., Weibel, T., Balow, J. E., & Brady, R. O. (2001) · JAMA · doi:10.1001/jama.285.21.2743 · Cited by 1,302
Enzymatic Defect in Fabry's Disease: Ceramidetrihexosidase Deficiency
Brady, R. O., Gal, A. E., Bradley, R. M., Martensson, E., Warshaw, A. L., & Laster, L. (1967) · New England Journal of Medicine · doi:10.1056/nejm196705252762101 · Cited by 1,053
High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*
Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H., Ponzone, A., & Desnick, R. J. (2006) · The American Journal of Human Genetics · doi:10.1086/504601 · Cited by 1,008
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
Mehta, A., Ricci, R., Widmer, U., Dehout, F., Garcia de Lorenzo, A., Kampmann, C., Linhart, A., Sunder‐Plassmann, G., Ries, M., & Beck, M. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01309.x · Cited by 848
Desnick, R. J., Brady, R., Barranger, J., Collins, A. J., Germain, D. P., Goldman, M., Grabowski, G., Packman, S., & Wilcox, W. R. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-4-200302180-00014 · Cited by 766
Self-citationAn Atypical Variant of Fabry's Disease in Men with Left Ventricular Hypertrophy
Nakao, S., Takenaka, T., Maeda, M., Kodama, C., Tanaka, A., Tahara, M., Yoshida, A., Kuriyama, M., Hayashibe, H., Sakuraba, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330504 · Cited by 763
MacDermot, K. D., Holmes, A., & Miners, A. H. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.11.769 · Cited by 681
The Factor Structure of the SF-36 Health Survey in 10 Countries
Ware, J. E., Kosinski, M., Gandek, B., Aaronson, N. K., Apolone, G., Bech, P., Brazier, J., Bullinger, M., Kaasa, S., Leplège, A., et al. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00107-3 · Cited by 655
α-Galactosidase A deficiency. Fabry disease
Desnick, R. J. (2001) · Cited by 605
Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy
Sachdev, B., Takenaka, T., Teraguchi, H., Tei, C., Lee, P., McKenna, W. J., & Elliott, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000012626.81324.38 · Cited by 570
Self-citationAgalsidase-Beta Therapy for Advanced Fabry Disease: A Randomized Trial
Banikazemi, M., Bultas, J., Waldek, S., Wilcox, W. R., Whitley, C. B., McDonald, M., Finkel, R., Packman, S., Bichet, D. G., Warnock, D. G., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00148 · Cited by 569
Self-citationPrevalence of Fabry disease in patients with cryptogenic stroke: a prospective study
Rolfs, A., Böttcher, T., Zschiesche, M., Morris, P., Winchester, B., Bauer, P., Walter, U., Mix, E., Löhr, M., Harzer, K., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67635-0 · Cited by 464
BRANTON, M. H., SCHIFFMANN, R., SABNIS, S. G., MURRAY, G. J., QUIRK, J. M., ALTARESCU, G., GOLDFARB, L., BRADY, R. O., BALOW, J. E., AUSTIN, H. A., et al. (2002) · Medicine · doi:10.1097/00005792-200203000-00003 · Cited by 461
Germain, D. P., Waldek, S., Banikazemi, M., Bushinsky, D. A., Charrow, J., Desnick, R. J., Lee, P., Loew, T., Vedder, A. C., Abichandani, R., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080816 · Cited by 438
Self-citationNakao, S., Kodama, C., Takenaka, T., Tanaka, A., Yasumoto, Y., Yoshida, A., Kanzaki, T., Enriquez, A. L. D., Eng, C. M., Tanaka, H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00160.x · Cited by 436
Self-citationFabry disease: Guidelines for the evaluation and management of multi-organ system involvement
Eng, C. M., Germain, D. P., Banikazemi, M., Warnock, D. G., Wanner, C., Hopkin, R. J., Bultas, J., Lee, P., Sims, K., Brodie, S. E., et al. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000237866.70357.c6 · Cited by 411
Self-citationLong-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease
Wilcox, W. R., for the International Fabry Disease Study Group, Banikazemi, M., Guffon, N., Waldek, S., Lee, P., Linthorst, G. E., Desnick, R. J., & Germain, D. P. (2004) · The American Journal of Human Genetics · doi:10.1086/422366 · Cited by 404
Self-citationEng, C. M., Banikazemi, M., Gordon, R. E., Goldman, M., Phelps, R., Kim, L., Gass, A., Winston, J., Dikman, S., Fallon, J. T., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318809 · Cited by 385
Self-citationChang, L., Toner, B. B., Fukudo, S., Guthrie, E., Locke, G. R., Norton, N. J., & Sperber, A. D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.09.071 · Cited by 369
Lowrie, E. G., Curtin, R. B., LePain, N., & Schatell, D. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00361-5 · Cited by 325
Methods for Validating and Norming Translations of Health Status Questionnaires
Gandek, B., & Ware, J. E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00086-9 · Cited by 324
Wang, R. Y., Lelis, A., Mirocha, J., & Wilcox, W. R. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31802d8321 · Cited by 305
Self-citationNatural history of Fabry disease in females in the Fabry Outcome Survey
Deegan, P. B., Baehner, A. F., Barba Romero, M.-Á., Hughes, D. A., Kampmann, C., & Beck, M. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036327 · Cited by 304
Cross-Cultural Comparisons of the Content of SF-36 Translations across 10 Countries
Wagner, A. K., Gandek, B., Aaronson, N. K., Acquadro, C., Alonso, J., Apolone, G., Bullinger, M., Bjorner, J., Fukuhara, S., Kaasa, S., et al. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00083-3 · Cited by 293
Anderson–Fabry disease: Clinical manifestations of disease in female heterozygotes
Whybra, C., Kampmann, C., Willers, I., Davies, J., Winchester, B., Kriegsmann, J., Brühl, K., Gal, A., Bunge, S., & Beck, M. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1012993305223 · Cited by 276
Fabry disease: overall effects of agalsidase alfa treatment
Beck, M., Ricci, R., Widmer, U., Dehout, F., De Lorenzo, A. G., Kampmann, C., Linhart, A., Sunder‐Plassmann, G., Houge, G., Ramaswami, U., et al. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01424.x · Cited by 224
Ries, M., Gupta, S., Moore, D. F., Sachdev, V., Quirk, J. M., Murray, G. J., Rosing, D. R., Robinson, C., Schaefer, E., Gal, A., et al. (2005) · Pediatrics · doi:10.1542/peds.2004-1678 · Cited by 209
Results of a Nationwide Screening for Anderson-Fabry Disease among Dialysis Patients
Kotanko, P., Kramar, R., Devrnja, D., Paschke, E., Voigtla[Combining Diaeresis]nder, T., Auinger, M., Demmelbauer, K., Lorenz, M., Hauser, A.-C., Kofler, H.-J. D., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000124671.61963.1e · Cited by 199
Enzyme replacement therapy improves function of C-, Aδ-, and Aβ-nerve fibers in Fabry neuropathy
Hilz, M. J., Brys, M., Marthol, H., Stemper, B., & Dütsch, M. (2004) · Neurology · doi:10.1212/01.wnl.0000118207.84514.40 · Cited by 170
Small Fiber Dysfunction Predominates in Fabry Neuropathy
Dütsch, M., Marthol, H., Stemper, B., Bryś, M., Haendl, T., & Hilz, M. J. (2002) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200212000-00011 · Cited by 154
Hoffmann, B., de Lorenzo, A. G., Mehta, A. B., Beck, M., Widmer, U., & Ricci, R. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.025791 · Cited by 148
Gupta, S. N., Ries, M., Kotsopoulos, S., & Schiffmann, R. (2005) · Medicine · doi:10.1097/01.md.0000178976.62537.6b · Cited by 122
Natural history of the cerebrovascular complications of Fabry disease
Mehta, A. B., & Ginsberg, L. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb02106.x · Cited by 91
Miners, A. H., Holmes, A. M., Sherr, L., Jenkinson, C., & MacDermot, K. D. (2002) · Quality of Life Research · doi:10.1023/a:1015009210639 · Cited by 72
Chronic airflow obstruction in Fabry's disease
Rosenberg, D. M., Ferrans, V. J., Fulmer, J. D., et al. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90224-7 · Cited by 64
Kitagawa, T., Ishige, N., Suzuki, K., Ōwada, M., Ohashi, T., Kobayashi, M., Eto, Y., Tanaka, A., Mills, K. A., WINCHESTER, B. G., et al. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.01.007 · Cited by 60
Bierer, G. B., Balfe, D. L., Wilcox, W. R., & Mosenifar, Z. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0361-5 · Cited by 58
Self-citationStreet, N., Yi, M., Bailey, L. A., & Hopkin, R. J. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000223545.63012.5a · Cited by 56
Self-citationERICKSON, S. R., CHRISTIAN, R. D., KIRKING, D. M., & HALMAN, L. J. (2002) · Respiratory Medicine · doi:10.1053/rmed.2001.1274 · Cited by 45
Cardiopulmonary Exercise Testing in Fabry Disease
Bierer, G. B., Kamangar, N., Balfe, D. L., Wilcox, W. R., & Mosenifar, Z. (2005) · Respiration · doi:10.1159/000087675 · Cited by 32
Self-citation
Cited by
Germain, D. P. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-30 · Cited by 1,198
Self-citationZarate, Y. A., & Hopkin, R. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61589-5 · Cited by 795
Self-citationFabry disease revisited: Management and treatment recommendations for adult patients
Ortiz, A., Germain, D. P., Desnick, R. J., Politei, J., Mauer, M., Burlina, A., Eng, C., Hopkin, R. J., Laney, D., Linhart, A., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.02.014 · Cited by 650
Self-citationMiller, D. T., Lee, K., Chung, W. K., Gordon, A. S., Herman, G. E., Klein, T. E., Stewart, D. R., Amendola, L. M., Adelman, K., Bale, S. J., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01172-3 · Cited by 535
X‐chromosome inactivation in female patients with Fabry disease
Echevarria, L., Benistan, K., Toussaint, A., Dubourg, O., Hagege, A. A., Eladari, D., Jabbour, F., Beldjord, C., De Mazancourt, P., & Germain, D. P. (2016) · Clinical Genetics · doi:10.1111/cge.12613 · Cited by 424
Self-citation
Metadata
- Authors
- Wilcox, W. R., Oliveira, J. P., Hopkin, R. J., Ortiz, A., Banikazemi, M., Feldt-Rasmussen, U., Sims, K., Waldek, S., Pastores, G. M., Lee, P., Eng, C. M., Marodi, L., Stanford, K. E., Breunig, F., Wanner, C., Warnock, D. G., Lemay, R. M., & Germain, D. P.
- Venue
- Molecular Genetics and Metabolism
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 93
- Issue
- 2
- Pages
- 112-128
- ISSN
- 1096-7192 (ISSN-L)
- OpenAlex
- W2026893678
- Cited by
- 544
- References
- 48
- FWCI
- 21.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.